Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 2, 2011, Pages 191-201

  Hempel, Nadine ^a   Carrico, Pauline M ^b   Melendez, J Andres ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b SUNY EMPIRE STATE COLLEGE   (United States)

Author keywords

Hydrogen peroxide; Matrix metalloproteinases; Metastasis; Signal transduction; Superoxide dismutase

Indexed keywords

COLLAGENASE 3; FREE RADICAL; GELATINASE A; GELATINASE B; HYDROGEN PEROXIDE; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MANGANESE SUPEROXIDE DISMUTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 26; STROMELYSIN; STROMELYSIN 2; TRANSCRIPTION FACTOR AP 1;

CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL SURVIVAL; HUMAN; METASTASIS; MITOCHONDRION; OXIDATION REDUCTION REACTION; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 79953793364     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011795255911     Document Type: Review

References (130)

1. Oberley, L.W.; G.R. Buettner. Role of superoxide dismutase in cancer: a review. Cancer Res., 1979, 39(4), 1141-1149.
2. Bravard, A.; L. Sabatier; F. Hoffschir; M. Ricoul; C. Luccioni; B. Dutrillaux. SOD2: a new type of tumor-suppressor gene? Int. J. Cancer, 1992, 51(3), 476-480.
3. Borrello, S.; M.E. De Leo; T. Galeotti. Defective gene expression of MnSOD in cancer cells. Mol. Aspects Med., 1993, 14(3), 253-258.
4. Soini, Y.; J.P. Kallio; P. Hirvikoski; H. Helin; P. Kellokumpu-Lehtinen; S.W. Kang; T.L. Tammela; M. Peltoniemi; P.M. Martikainen; V.L. Kinnula. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS, 2006, 114(5), 329-337.
5. Cobbs, C.S.; D.S. Levi; K. Aldape; M.A. Israel. Manganese superoxide dismutase expression in human central nervous system tumors. Cancer Res., 1996, 56(14), 3192-3195.
6. Tews, D.S. Cell death and oxidative stress in gliomas. Neuropathol. Appl. Neurobiol., 1999, 25(4), 272-284.
7. Zhong, W.; T. Yan; R. Lim; L.W. Oberley. Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic. Biol. Med., 1999, 27(11-12), 1334-1345.
8. Haapasalo, H.; M. Kylaniemi; N. Paunul; V.L. Kinnula; Y. Soini. Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol., 2003, 13(2), 155-164.
9. French, P.J.; S.M. Swagemakers; J.H. Nagel; M.C. Kouwenhoven; E. Brouwer; P. van der Spek; T.M. Luider; J.M. Kros; M.J. van den Bent; P.A. Sillevis Smitt. Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res., 2005, 65(24), 11335-11344.
10. Jarvela, S.; H. Bragge; N. Paunu; T. Jarvela; L. Paljarvi; H. Kalimo; P. Helen; V. Kinnula; Y. Soini; H. Haapasalo. Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival. J. Neurooncol., 2006, 77(2), 131-140.
11. Nordfors, K.; J. Haapasalo; P. Helen; A. Paetau; L. Paljarvi; H. Kalimo; V.L. Kinnula; Y. Soini; H. Haapasalo. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas. Clin. Neuropathol., 2007, 26(5), 210-218.
12. Park, C.K.; J.H. Jung; M.J. Moon; Y.Y. Kim; J.H. Kim; S.H. Park; C.Y. Kim; S.H. Paek; D.G. Kim; H.W. Jung; B.K. Cho. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma. Oncology, 2009, 77(3-4), 178-181.
13. Izutani, R.; S. Asano; M. Imano; D. Kuroda; M. Kato; H. Ohyanagi. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol., 1998, 33(6), 816-822.
14. Hermann, B.; Y. Li; M.B. Ray; J.M. Wo; R.C.2. Martin. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch. Surg., 2005, 140(12), 1204-1209.
15. Qi, Y.; J.F. Chiu; L. Wang; D.L. Kwong; Q.Y. He. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics, 2005, 5(11), 2960-2971.
16. Salzman, R.; K. Kankova; L. Pacal; J. Tomandl; Z. Horakova; R. Kostrica. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma, 2007, 54(4), 321-325.
17. Lo, W.Y.; M.H. Tsai; Y. Tsai; C.H. Hua; F.J. Tsai; S.Y. Huang; C.H. Tsai; C.C. Lai. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta, 2007, 376(1-2).
18. Ye, H.; A. Wang; B.S. Lee; T. Yu; S. Sheng; T. Peng; S. Hu; D.L. Crowe; X. Zhou. Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics, 2008, 5(2), 85-94.
19. Svensk, A.M.; Y. Soini; P. Paakko; P. Hiravikoski; V.L. Kinnula. Differential expression of superoxide dismutases in lung cancer. Am. J. Clin. Pathol., 2004, 122(3), 395-404.
20. Kinnula, V.L.; P. Pietarinen-Runtti; K. Raivio; K. Kahlos; K. Pelin; K. Mattson; K. Linnainmaa. Manganese superoxide dismutase in human pleural mesothelioma cell lines. Free Radic. Biol. Med., 1996, 21(4), 527-532.
21. Kahlos, K.; S. Anttila; T. Asikainen; K. Kinnula; K.O. Raivio; K. Mattson; K. Linnainmaa; V.L. Kinnula. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am. J. Respir. Cell Mol. Biol., 1998, 18(4), 570-580.
22. Kahlos, K.; Y. Soini; P. Paakko; M. Saily; K. Linnainmaa; V.L. Kinnula. Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma. Int. J. Cancer, 2000, 88(1), 37-43.
23. Kahlos, K.; P. Paakko; E. Kurttila; Y. Soini; V.L. Kinnula. Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma. Br J. Cancer, 2000, 82(5), 1022-1029.
24. Skrzycki, M.; D. Scibior; M. Podsiad; H. Czeczot. Activity and protein level of CuZnSOD and MnSOD in benign and malignant liver tumors. Clin. Biochem., 2008, 41(1-2), 91-96.
25. Malafa, M.; J. Margenthaler; B. Webb; L. Neitzel; M. Christophersen. MnSOD expression is increased in metastatic gastric cancer. J. Surg. Res., 2000, 88(2), 130-134.
26. Kim, J.J.; S.W. Chae; G.C. Hur; S.J. Cho; M.K. Kim; J. Choi; S.Y. Nam; W.H. Kim; H.K. Yang; B.L. Lee. Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology, 2002, 70(6), 353-360.
27. Nozoe, T.; M. Honda; S. Inutsuka; M. Yasuda; D. Korenaga. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol. Rep., 2003, 10(1), 39-43.
28. Monari, M.; A. Trinchero; C. Calabrese; O. Cattani; G.P. Serrazanetti; J. Foschi; A. Fabbri; D. Zahlane; G. Di Febo; V. Tonini; M. Cervellera; M.R. Tosi; V. Tugnoli. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers, 2006, 11(6), 574-584.
29. Takeno, A.; I. Takemasa; Y. Doki; M. Yamasaki; H. Miyata; S. Takiguchi; Y. Fujiwara; K. Matsubara; M. Monden. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br. J. Cancer, 2008, 99(8), 1307-1315.
30. Monari, M.; J. Foschi; C. Calabrese; G. Liguori; G. Di Febo; F. Rizzello; P. Gionchetti; A. Trinchero; G.P. Serrazanetti. Implications of antioxidant enzymes in human gastric neoplasms. Int. J. Mol. Med., 2009, 24(5), 693-700.
31. Gulubova, M.; T. Vlaykova. Expression of the xenobiotic-and reactive oxygen species-detoxifying enzymes, GST-pi, Cu/Zn-SOD, and Mn-SOD in the endocrine cells of colorectal cancer. Int. J. Colorectal Dis., 2010, 25(12), 1397-1405.
32. Lewis, A.; J. Du; J. Liu; J.M. Ritchie; L.W. Oberley; J.J. Cullen. Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin. Exp. Metastasis, 2005, 22(7), 523-532.
33. Nozoe, T.; M. Honda; S. Inutsuka; M. Yasuda; D. Korenaga. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol. Rep., 2003, 10(1), 39-43.
34. Quiros, I.; R.M. Sainz; D. Hevia; O. Garcia-Suarez; A. Astudillo; M. Rivas; J.C. Mayo. Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. Int. J. Cancer, 2009, 125(7), 1497-1504.
35. Giesing, M.; B. Suchy; G. Driesel; D. Molitor. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostatespecific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy. BJU Int., 2010, 105(7), 1000-1010.
36. Hempel, N.; H. Ye; B. Abessi; B. Mian; J.A. Melendez. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic. Biol. Med., 2009, 46(1), 42-50.
37. Tsanou, E.; E. Ioachim; E. Briasoulis; K. Damala; A. Charchanti; V. Karavasilis; N. Pavlidis; N.J. Agnantis. Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histol. Histopathol., 2004, 19(3), 807-813.
38. Ria, F.; M. Landriscina; F. Remiddi; R. Rosselli; M. Iacoangeli; M. Scerrati; G. Pani; S. Borrello; T. Galeotti. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br. J. Cancer, 2001, 84(4), 529-534.
39. Yang, F.; Z.Q. Xiao; X.Z. Zhang; C. Li; P.F. Zhang; M.Y. Li; Y. Chen; G.Q. Zhu; Y. Sun; Y.F. Liu; Z.C. Chen. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J. Proteome Res., 2007, 6(2), 751-758.
40. Adzic, M.; A. Niciforovic; Z. Neskovic-Konstantinovic; M.B. Radojcic. Superoxide dismutases and p53 protein levels in blood cells of breast cancer patients. J. BUON, 2004, 9(3), 283-287.
41. Giesing, M.; B. Suchy; G. Driesel; D. Molitor. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostatespecific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy. BJU Int., 2010, 105(7).
42. Hempel, N.; H. Ye; B. Abessi; B. Mian; J.A. Melendez. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic. Biol. Med., 2009, 46(1), 42-50.
43. Omar, R.A.; Y.J. Chyan; A.C. Andorn; B. Poeggeler; N.K. Robakis; M.A. Pappolla. Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease. J. Alzheimers. Dis., 1999, 1(3), 139-145.
44. Shan, W.; W. Zhong; R. Zhao; T.D. Oberley. Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression. Free Radic. Biol. Med., 2010, 49(12), 2078-2087.
45. Clerch, L.B.; D. Massaro; A. Berkovich. Molecular mechanisms of antioxidant enzyme expression in lung during exposure to and recovery from hyperoxia. Am. J. Physiol, 1998, 274(3 Pt 1), L313-L319.
46. John, J.P.; A. Pollak; G. Lubec. Complete sequencing and oxidative modification of manganese superoxide dismutase in medulloblastoma cells. Electrophoresis, 2009, 30(17), 3006-3016.
47. Ramilo, C.A.; V. Leveque; Y. Guan; J.R. Lepock; J.A. Tainer; H.S. Nick; D.N. Silverman. Interrupting the hydrogen bond network at the active site of human manganese superoxide dismutase. J. Biol. Chem., 1999, 274(39), 27711-27716.
48. Davis, C.A.; A.S. Hearn; B. Fletcher; J. Bickford; J.E. Garcia; V. Leveque; J.A. Melendez; D.N. Silverman; J. Zucali; A. Agarwal; H.S. Nick. Potent anti-tumor effects of an active site mutant of human manganese-superoxide dismutase. Evolutionary conservation of product inhibition. J. Biol. Chem., 2004, 279(13), 12769-12776.
49. Macmillan-Crow, L.A.; J.P. Crow; J.D. Kerby; J.S. Beckman; J.A. Thompson. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA, 1996, 93(21), 11853-11858.
50. Sutton, A.; H. Khoury; C. Prip-Buus; C. Cepanec; D. Pessayre; F. Degoul. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics, 13(3), 2003, 145-157.
51. Bag, A.; N. Bag. Target Sequence Polymorphism of Human Manganese Superoxide Dismutase Gene and Its Association with Cancer Risk: A Review. Cancer Epidemiol. Biomarkers Prev., 2008, 17(12), 3298-3305.
52. Huang, Y.; J. Peng; L.W. Oberley; F.E. Domann. Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5' CpG island. Free Radic. Biol. Med., 1997, 23(2), 314-320.
53. Huang, Y.; T. He; F.E. Domann. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol., 1999, 18(8), 643-652.
54. Hitchler, M.J.; L.W. Oberley; F.E. Domann. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic. Biol. Med., 2008, 45(11), 1573-1580.
55. Rohrdanz, E.; R. Kahl. Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Radic. Biol. Med., 1998, 24(1), 27-38.
56. Josson, S.; Y. Xu; F. Fang; S.K. Dhar; D.K. St Clair; W.H. St Clair. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene, 2006, 25(10), 1554-1559.
57. Pani, G.; R. Colavitti; B. Bedogni; S. Fusco; D. Ferraro; S. Borrello; T. Galeotti. Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Curr Med Chem, 2004, 11(10), 1299-1308.
58. Dhar, S.K.; Y. Xu; D.K. St Clair. Nuclear factor kappaB-and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. J. Biol. Chem., 285(13), 2010, 9835-9846.
59. Pani, G.; B. Bedogni; R. Anzevino; R. Colavitti; B. Palazzotti; S. Borrello; T. Galeotti. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res., 2000, 60(16), 4654-4660.
60. Zhao, Y.; L. Chaiswing; J.M. Velez; I. Batinic-Haberle; N.H. Colburn; T.D. Oberley; D.K. St Clair. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res., 2005, 65(9), 3745-3750.
61. Perera, C.S.; D.K. St Clair; C.J. McClain. Differential regulation of manganese superoxide dismutase activity by alcohol and TNF in human hepatoma cells. Arch. Biochem. Biophys., 1995, 323(2), 471-476.
62. Siemankowski, L.M.; J. Morreale; M.M. Briehl. Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD. Free Radic. Biol. Med., 1999, 26(7-8), 919-924.
63. Whitsett, J.A.; J.C. Clark; J.R. Wispe; G.S. Pryhuber. Effects of TNF-alpha and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro. Am. J. Physiol., 1992, 262(6 Pt 1), L688-L693.
64. Mocellin, S.; D. Nitti. TNF and cancer: the two sides of the coin. Front Biosci., 2008, 13, 2774-2783.
65. Szlosarek, P.; K.A. Charles; F.R. Balkwill. Tumour necrosis factoralpha as a tumour promoter. Eur. J. Cancer, 2006, 42(6), 745-750.
66. Minig, V.; Z. Kattan; J. van Beeumen; E. Brunner; P. Becuwe. Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells. J. Biol. Chem., 2009, 284(21), 14165-14176.
67. Holley, A.K.; K.K. Kiningham; D.R. Spitz; D.P. Edwards; J.T. Jenkins; M.R. Moore. Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol., 2009, 117(1-3), 23-30.
68. Liu, X.; J. Yu; L. Jiang; A. Wang; F. Shi; H. Ye; X. Zhou. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics, 2009, 6(3), 131-139.
69. Zhao, Y.; T.D. Oberley; L. Chaiswing; S.M. Lin; C.J. Epstein; T.T. Huang; D. St Clair. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene, 2002, 21(24), 3836-3846.
70. Oberley, L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacother., 2005, 59(4), 143-148.
71. Miele, M.E.; C.T. McGary; D.R. Welch.SOD2 (MnSOD) does not suppress tumorigenicity or metastasis of human melanoma C8161 cells. Anticancer Res., 1995, 15(5B), 2065-2070.
72. Connor, K.M.; N. Hempel; K.K. Nelson; G. Dabiri; A. Gamarra; J. Belarmino; W.L. Van De; B.M. Mian; J.A. Melendez. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res., 2007, 67(21), 10260-10267.
73. Nelson, K.K.; A.C. Ranganathan; J. Mansouri; A.M. Rodriguez; K.M. Providence; J.L. Rutter; K. Pumiglia; J.A. Bennett; J.A. Melendez. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res., 2003, 9(1), 424-432.
74. Lam, E.W.; R. Zwacka; E.A. Seftor; D.R. Nieva; B.L. Davidson; J.F. Engelhardt; M.J. Hendrix; L.W. Oberley. Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. Free Radic. Biol. Med., 1999, 27(5-6), 572-579.
75. Lemaitre, V.; J. D'Armiento. Matrix metalloproteinases in development and disease. Birth Defects Res. C. Embryo. Today, 2006, 78(1), 1-10.
76. Pardo, A.; M. Selman. MMP-1: the elder of the family. Int. J Biochem. Cell Biol., 2005, 37(2), 283-288.
77. Gialeli, C.; A.D. Theocharis; N.K. Karamanos. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J., 2011, 278(1), 16-27.
78. Zhang, H.J.; W. Zhao; S. Venkataraman; M.E. Robbins; G.R. Buettner; K.C. Kregel; L.W. Oberley. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J. Biol. Chem., 2002, 277(23), 20919-20926.
79. Kattan, Z.; V. Minig; P. Leroy; M. Dauca; P. Becuwe. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res. Treat., 2008, 108(2), 203-215.
80. Dinney, C.P.; R. Fishbeck; R.K. Singh; B. Eve; S. Pathak; N. Brown; B. Xie; D. Fan; C.D. Bucana; I.J. Fidler. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 1995, 154(4), 1532-1538.
81. Nelson, K.K.; J.A. Melendez. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med., 2004, 37(6), 768-784.
82. Nelson, K.K.; S. Subbaram; K.M. Connor; J. Dasgupta; X.F. Ha; T.C. Meng; N.K. Tonks; J.A. Melendez. Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J. Biol. Chem., 2006, 281(20), 14100-14110.
83. Ranganathan, A.C.; K.K. Nelson; A.M. Rodriguez; K.H. Kim; G.B. Tower; J.L. Rutter; C.E. Brinckerhoff; T.T. Huang; C.J. Epstein; J.J. Jeffrey; J.A. Melendez. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J. Biol. Chem., 2001, 276(17), 14264-14270.
84. Yan, C.; D.D. Boyd. Regulation of matrix metalloproteinase gene expression. J. Cell Physiol., 2007, 211(1), 19-26.
85. Kar, S.; S. Subbaram; P.M. Carrico; J.A. Melendez. Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir. Physiol Neurobiol., 2010, 174(3), 299-306.
86. Clark, I.M.; T.E. Swingler; C.L. Sampieri; D.R. Edwards. The regulation of matrix metalloproteinases and their inhibitors. Int. J Biochem. Cell Biol., 2008, 40(6-7), 1362-1378.
87. Westermarck, J.; A. Seth; V.M. Kahari. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene, 1997, 14(22), 2651-2660.
88. Whitmarsh, A.J.; R.J. Davis. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 1996, 74(10), 589-607.
89. Clerk, A.; S.J. Fuller; A. Michael; P.H. Sugden. Stimulation of "stress-regulated" mitogen-activated protein kinases (stressactivated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem., 1998, 273(13), 7228-7234.
90. Frost, J.A.; T.D. Geppert; M.H. Cobb; J.R. Feramisco. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA, 1994, 91(9), 3844-3848.
91. Westermarck, J.; V.M. Kahari. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 1999, 13(8), 781-792.
92. Wenk, J.; P. Brenneisen; M. Wlaschek; A. Poswig; K. Briviba; T.D. Oberley; K. Scharffetter-Kochanek. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol. Chem., 1999, 274(36), 25869-25876.
93. Tonks, N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell, 2005, 121(5), 667-670.
94. Leslie, N.R.; C.P. Downes. PTEN function: how normal cells control it and tumour cells lose it. Biochem. J., 2004, 382(Pt 1), 1-11.
95. Leslie, N.R.; D. Bennett; Y.E. Lindsay; H. Stewart; A. Gray; C.P. Downes. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J., 2003, 22(20), 5501-5510.
96. Connor, K.M.; S. Subbaram; K.J. Regan; K.K. Nelson; J.E. Mazurkiewicz; P.J. Bartholomew; A.E. Aplin; Y.T. Tai; J. Aguirre-Ghiso; S.C. Flores; J.A. Melendez. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem., 2005, 280(17), 16916-16924.
97. Franca-Koh, J.; Y. Kamimura; P.N. Devreotes. Leading-edge research: PtdIns(3,4,5)P3 and directed migration. Nat. Cell Biol., 2007, 9(1), 15-17.
98. Leslie, N.R.; X. Yang; C.P. Downes; C.J. Weijer. PtdIns(3,4,5) P(3)-dependent and-independent roles for PTEN in the control of cell migration. Curr. Biol., 2007, 17(2), 115-125.
99. Kriegel, A.J.; Y. Fang; Y. Liu; Z. Tian; D. Mladinov; I.R. Matus; X. Ding; A.S. Greene; M. Liang. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res., 2010, 38(22), 8338-8347.
100. Payne, S.L.; B. Fogelgren; A.R. Hess; E.A. Seftor; E.L. Wiley; S.F. Fong; K. Csiszar; M.J. Hendrix; D.A. Kirschmann. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res., 2005, 65(24), 11429-11436.
101. Dasgupta, J.; S. Kar; R. Liu; J. Joseph; B. Kalyanaraman; S.J. Remington; C. Chen; J.A. Melendez. Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell Physiol., 2010, 225(1), 52-62.
102. Kamata, H.; S. Honda; S. Maeda; L. Chang; H. Hirata; M. Karin. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120(5), 649-661.
103. Epperly, M.W.; C.A. Sikora; S.J. DeFilippi; J.A. Gretton; Q. Zhan; D.W. Kufe; J.S. Greenberger. Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat. Res., 2002, 157(5), 568-577.
104. Mohr, A.; C. Buneker; R.P. Gough; R.M. Zwacka. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene, 2008, 27(6), 763-774.
105. Wong, G.H.; D.V. Goeddel. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science, 1988, 242(4880), 941-944.
106. Wong, G.H.; J.H. Elwell; L.W. Oberley; D.V. Goeddel. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 1989, 58(5), 923-931.
107. Zhao, Y.; K.K. Kiningham; S.M. Lin; D.K. St Clair. Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFkappaB pathways. Antioxid. Redox Signal, 2001, 3(3), 375-386.
108. Sompol, P.; Y. Xu; W. Ittarat; C. Daosukho; D. St Clair. NFkappaB-associated MnSOD induction protects against betaamyloid-induced neuronal apoptosis. J. Mol. Neurosci., 2006, 29(3), 279-288.
109. Mantymaa, P.; T. Siitonen; T. Guttorm; M. Saily; V. Kinnula; E.R. Savolainen; P. Koistinen. Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br. J. Haematol., 2000, 108(3), 574-581.
110. Daosukho, C.; W. Ittarat; S.M. Lin; D.B. Sawyer; K. Kiningham; Y.C. Lien; D.K. St Clair. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM). J. Mol. Cell Cardiol, 2005, 39(5), 792-803.
111. Dasgupta, J.; S. Subbaram; K.M. Connor; A.M. Rodriguez; O. Tirosh; J.S. Beckman; D. Jourd'heuil; J.A. Melendez. Manganese Superoxide Dismutase Protects from TNF-alpha-Induced Apoptosis by Increasing the Steady-State Production of H(2)O(2). Antioxid. Redox. Signal., 2006, 8(7-8), 1295-1305.
112. Diehn, M.; R.W. Cho; N.A. Lobo; T. Kalisky; M.J. Dorie; A.N. Kulp; D. Qian; J.S. Lam; L.E. Ailles; M. Wong; B. Joshua; M.J. Kaplan; I. Wapnir; F.M. Dirbas; G. Somlo; C. Garberoglio; B. Paz; J. Shen; S.K. Lau; S.R. Quake; J.M. Brown; I.L. Weissman; M.F. Clarke. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 2009, 458(7239), 780-783.
113. Brandt, W.D.; W. Matsui; J.E. Rosenberg; X. He; S. Ling; E.M. Schaeffer; D.M. Berman. Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Rev., 2009, 28(3-4), 291-304.
114. He, X.; L. Marchionni; D.E. Hansel; W. Yu; A. Sood; J. Yang; G. Parmigiani; W. Matsui; D.M. Berman. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells, 2009, 27(7), 1487-1495.
115. Cerutti, P.A. 1985. Prooxidant states and tumor promotion. Science, 227(4685), 375-381.
116. St Clair, D.K.; S. Porntadavity; Y. Xu; K. Kiningham. Transcription regulation of human manganese superoxide dismutase gene. Methods Enzymol., 2002, 349, 306-312.
117. Ishikawa, K.; K. Takenaga; M. Akimoto; N. Koshikawa; A. Yamaguchi; H. Imanishi; K. Nakada; Y. Honma; J. Hayashi. ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 2008, 320(5876), 661-664.
118. Kwei, K.A.; J.S. Finch; E.J. Thompson; G.T. Bowden. Transcriptional repression of catalase in mouse skin tumor progression. Neoplasia., 2004, 6(5), 440-448.
119. Min, J.Y.; S.O. Lim; G. Jung. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett., 2010, 584(11), 2427-2432.
120. Cao, C.; Y. Leng; X. Liu; Y. Yi; P. Li; D. Kufe. Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochemistry, 2003, 42(35), 10348-10353.
121. Graham, K.A.; M. Kulawiec; K.M. Owens; X. Li; M.M. Desouki; D. Chandra; K.K. Singh. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol. Ther., 2010, 10(3), 223-231.
122. Yamaura, M.; J. Mitsushita; S. Furuta; Y. Kiniwa; A. Ashida; Y. Goto; W.H. Shang; M. Kubodera; M. Kato; M. Takata; T. Saida; T. Kamata. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res., 2009, 69(6), 2647-2654.
123. Wang, M.; J.S. Kirk; S. Venkataraman; F.E. Domann; H.J. Zhang; F.Q. Schafer; S.W. Flanagan; C.J. Weydert; D.R. Spitz; G.R. Buettner; L.W. Oberley. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene, 2005, 24(55), 8154-8166.
124. Kaewpila, S.; S. Venkataraman; G.R. Buettner; L.W. Oberley. Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. Cancer Res., 2008, 68(8), 2781-2788.
125. Wang, M.; J.S. Kirk; S. Venkataraman; F.E. Domann; H.J. Zhang; F.Q. Schafer; S.W. Flanagan; C.J. Weydert; D.R. Spitz; G.R. Buettner; L.W. Oberley. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene, 2005, 24(55), 8154-8166.
126. Melendez, J.A.; K.J. Davies. Manganese superoxide dismutase modulates interleukin-1alpha levels in HT-1080 fibrosarcoma cells. J. Biol. Chem., 1996, 271(31), 18898-18903.
127. Freije, W.A.; F.E. Castro-Vargas; Z. Fang; S. Horvath; T. Cloughesy; L.M. Liau; P.S. Mischel; S.F. Nelson. Gene expression profiling of gliomas strongly predicts survival. Cancer Res., 2004, 64(18), 6503-6510.
128. Tomlins, S.A.; R. Mehra; D.R. Rhodes; X. Cao; L. Wang; S.M. Dhanasekaran; S. Kalyana-Sundaram; J.T. Wei; M.A. Rubin; K.J. Pienta; R.B. Shah; A.M. Chinnaiyan. 2007, Integrative molecular concept modeling of prostate cancer progression. Nat Genet., 39(1), 41-51.
129. Ivshina, A.V.; J. George; O. Senko; B. Mow; T.C. Putti; J. Smeds; T. Lindahl; Y. Pawitan; P. Hall; H. Nordgren; J.E. Wong; E.T. Liu; J. Bergh; V.A. Kuznetsov; L.D. Miller. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res., 2006, 66(21), 10292-10301.
130. van't Veer, L.J.; H. Dai; M.J. van de Vijver; Y.D. He; A.A. Hart; M. Mao; H.L. Peterse; K. van der Kooy; M.J. Marton; A.T. Witteveen; G.J. Schreiber; R.M. Kerkhoven; C. Roberts; P.S. Linsley; R. Bernards; S.H. Friend. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415(6871), 530-536.